Morgan Stanley Upgrades Evotec to Overweight, Raises Price Target to $16
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst James Quigley upgraded Evotec (NASDAQ:EVO) from Equal-Weight to Overweight and raised the price target from $12 to $16.
June 23, 2023 | 9:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evotec (NASDAQ:EVO) has been upgraded to Overweight by Morgan Stanley, with a raised price target of $16.
Morgan Stanley's upgrade to Overweight and raised price target for Evotec indicates a positive outlook for the stock. This could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100